TrialBritish journal of clinical pharmacology2015

Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteers.

Goran Westerberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.